{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:52:18Z","timestamp":1792803138126,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.amjmed.2019.03.022","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T13:37:41Z","timestamp":1554298661000},"page":"1069-1077.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study"],"prefix":"10.1016","volume":"132","author":[{"given":"Simone Y.","family":"Loo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dell\u2019Aniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana Hoi Yun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Renoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.amjmed.2019.03.022_bb0005","first-page":"2670","article-title":"Effects of testosterone replacement in hypogonadal men","volume":"85","author":"Snyder","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.amjmed.2019.03.022_bb0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1210\/jc.2013-3570","article-title":"Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011","volume":"99","author":"Layton","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.amjmed.2019.03.022_bb0015","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jamainternmed.2013.6895","article-title":"Trends in androgen prescribing in the United States, 2001 to 2011","volume":"173","author":"Baillargeon","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.amjmed.2019.03.022_bb0020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/cen.12178","article-title":"A UK epidemic of testosterone prescribing, 2001-2010","volume":"79","author":"Gan","year":"2013","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.amjmed.2019.03.022_bb0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2019.03.022_bb0030","author":"US Food and Drug Administration"},{"key":"10.1016\/j.amjmed.2019.03.022_bb0035","author":"European Medicines Agency"},{"issue":"11","key":"10.1016\/j.amjmed.2019.03.022_bb0040","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S2213-8587(16)30215-7","article-title":"Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews","volume":"4","author":"Onasanya","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"17","key":"10.1016\/j.amjmed.2019.03.022_bb0045","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.amjmed.2019.03.022_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085805","article-title":"Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men","volume":"9","author":"Finkle","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.amjmed.2019.03.022_bb0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jamainternmed.2016.9546","article-title":"Association of testosterone replacement with cardiovascular outcomes among men with androgen deficiency","volume":"177","author":"Cheetham","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"40","key":"10.1016\/j.amjmed.2019.03.022_bb0060","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehv346","article-title":"Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men","volume":"36","author":"Sharma","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2019.03.022_bb0065","author":"Health Canada"},{"issue":"13","key":"10.1016\/j.amjmed.2019.03.022_bb0070","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.2018.3182","article-title":"Evaluation and treatment of male hypogonadism","volume":"319","author":"Sargis","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.amjmed.2019.03.022_bb0075","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.amjmed.2019.03.022_bb0080","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2125.1998.00701.x","article-title":"Use of the UK General Practice Research Database for pharmacoepidemiology","volume":"45","author":"Garcia Rodriguez","year":"1998","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.amjmed.2019.03.022_bb0085","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/00002018-200427120-00004","article-title":"The General Practice Research Database","volume":"27","author":"Wood","year":"2004","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.amjmed.2019.03.022_bb0090","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"6732","key":"10.1016\/j.amjmed.2019.03.022_bb0095","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The Read clinical classification","volume":"300","author":"Chisholm","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2019.03.022_bb0100","author":"National Health Service: Business Services Authority"},{"issue":"5","key":"10.1016\/j.amjmed.2019.03.022_bb0105","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1592\/phco.23.5.686.32205","article-title":"Validity of the general practice research database","volume":"23","author":"Jick","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"572","key":"10.1016\/j.amjmed.2019.03.022_bb0110","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.3399\/bjgp10X483562","article-title":"Validity of diagnostic coding within the General Practice Research Database: a systematic review","volume":"60","author":"Khan","year":"2010","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.amjmed.2019.03.022_bb0115","doi-asserted-by":"crossref","first-page":"f2350","DOI":"10.1136\/bmj.f2350","article-title":"Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study","volume":"346","author":"Herrett","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.amjmed.2019.03.022_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/pds.2630030106","article-title":"The quality of information recorded on a UK database of primary care records: a study of hospitalizations due to hypoglycemia and other conditions","volume":"3","author":"Van Staa","year":"1994","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.amjmed.2019.03.022_bb0125","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.amjmed.2019.03.022_bb0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.amjmed.2019.03.022_bb0135","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.amjmed.2019.03.022_bb0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-6196(11)60964-6","article-title":"Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"82","author":"Haddad","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.amjmed.2019.03.022_bb0145","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis","volume":"95","author":"Fernandez-Balsells","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.amjmed.2019.03.022_bb0150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jama.2018.7999","article-title":"Testosterone prescribing in the united states, 2002-2016","volume":"320","author":"Baillargeon","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2019.03.022_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.maturitas.2017.08.013","article-title":"Testosterone replacement therapy and the risk of stroke in men: a systematic review","volume":"106","author":"Loo","year":"2017","journal-title":"Maturitas"},{"issue":"10","key":"10.1016\/j.amjmed.2019.03.022_bb0160","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/ijcp.12876","article-title":"Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)","volume":"70","author":"Maggi","year":"2016","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.amjmed.2019.03.022_bb0165","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/phar.1534","article-title":"Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study","volume":"35","author":"Etminan","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.amjmed.2019.03.022_bb0170","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-8587(16)00112-1","article-title":"Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study","volume":"4","author":"Wallis","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.amjmed.2019.03.022_bb0175","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/pds.4197","article-title":"Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism","volume":"26","author":"Renoux","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amjmed.2019.03.022_bb0180","article-title":"Testosterone treatment and risk of venous thromboembolism: population based case-control study","volume":"355","author":"Martinez","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.amjmed.2019.03.022_bb0185","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/cen.13084","article-title":"Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: a systematic review","volume":"85","author":"Albert","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"suppl A","key":"10.1016\/j.amjmed.2019.03.022_bb0190","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/S1096-6374(03)00059-5","article-title":"Testosterone and atherosclerosis","volume":"13","author":"von Eckardstein","year":"2003","journal-title":"Growth Hormon IGF Res"},{"issue":"11","key":"10.1016\/j.amjmed.2019.03.022_bb0195","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1161\/01.CIR.91.11.2742","article-title":"Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses","volume":"91","author":"Ajayi","year":"1995","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.amjmed.2019.03.022_bb0200","first-page":"60","article-title":"Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease","volume":"1","author":"Badimon","year":"2012","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"7","key":"10.1016\/j.amjmed.2019.03.022_bb0205","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.amjmed.2019.03.022_bb0210","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1532-5415.1995.tb05534.x","article-title":"Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels","volume":"43","author":"Drinka","year":"1995","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.amjmed.2019.03.022_bb0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/smrj.43","article-title":"Erythrocytosis and polycythemia secondary to testosterone replacement therapy in the aging male","volume":"3","author":"Jones","year":"2015","journal-title":"Sex Med Rev"},{"issue":"1","key":"10.1016\/j.amjmed.2019.03.022_bb0220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1208500","article-title":"Cardiovascular events and intensity of treatment in polycythemia vera","volume":"368","author":"Marchioli","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.amjmed.2019.03.022_bb0225","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0735-1097(03)00184-0","article-title":"Obstructive sleep apnea and cardiovascular disease","volume":"41","author":"Lattimore","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.amjmed.2019.03.022_bb0230","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1210\/jc.2003-030236","article-title":"The short-term effects of high-dose testosterone on sleep, breathing, and function in older men","volume":"88","author":"Liu","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.amjmed.2019.03.022_bb0235","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/jc.2011-2591","article-title":"Testosterone treatment and mortality in men with low testosterone levels","volume":"97","author":"Shores","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.amjmed.2019.03.022_bb0240","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society Clinical Practice Guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319302815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319302815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:17:02Z","timestamp":1757582222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934319302815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0002934319302815"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.03.022","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}